# Efficacy of Liposomal Bupivacaine Post Septorhinoplasty

> **NCT05964868** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Jessyka Lighthall** · enrollment: 72 (estimated)

## Conditions studied

- Rhinoplasty
- Pain Management

## Interventions

- **DRUG:** Liposomal Bupivacaine
- **DRUG:** 0.25% bupivacaine with 1:200,000 epinephrine
- **OTHER:** Placebo - Saline solution

## Key facts

- **NCT ID:** NCT05964868
- **Lead sponsor:** Jessyka Lighthall
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-02-05
- **Primary completion:** 2026-12
- **Final completion:** 2027-07
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05964868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05964868, "Efficacy of Liposomal Bupivacaine Post Septorhinoplasty". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05964868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*